We could not find any results for:
Make sure your spelling is correct or try broadening your search.
e-therapeutics veröffentlicht präklinische Daten zu ETX-148 auf dem EAHAD 2025 LONDON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- e-therapeutics plc, ein Unternehmen mit Fokus auf der Integration von...
e-therapeutics présentera des données précliniques relatives à l’ETX-148 lors de l’édition 2025 du Congrès annuel de l’EAHAD LONDRES, 05 févr. 2025 (GLOBE NEWSWIRE) -- e-therapeutics plc...
e-therapeutics to Present Preclinical Data on ETX-148 at EAHAD 2025 LONDON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to...
e-therapeutics Announces Business Updates and Interim Results LONDON, Oct. 31, 2024 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to...
AIM 09 May 2024 NOTICE 09/05/2024 - 07:00 NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM At the request of the company the following securities have been cancelled from trading...
e-Therapeutics plc 08 May 2024 e-therapeutics plc ("e-therapeutics" or "ETX" or the "Company") Last Day of Dealings on AIM London, UK, 8 May 2024 - e-therapeutics plc (AIM:...
FTSE Russell 03 May 2024 E-therapeutics (UK): Constituent Deletion Changes in FTSE UK Index Series 03 May 2024 Subject to the expected cancellation of trading on AIM for E-therapeutics...
e-Therapeutics plc 29 April 2024 e-therapeutics plc ("e-therapeutics" or "ETX" or the "Company") Result of General Meeting Matched Bargain Settlement Facility London, UK, 29...
e-Therapeutics PLC on Wednesday announced its intention to cancel its admission to AIM and instead explore the option ...
e-Therapeutics plc 10 April 2024 This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 9 | 9 | 9 | 0 | 0 | DE |
4 | 0 | 0 | 9 | 9 | 9 | 0 | 0 | DE |
12 | 0 | 0 | 9 | 9 | 9 | 0 | 0 | DE |
26 | 0 | 0 | 9 | 9 | 9 | 0 | 0 | DE |
52 | -6 | -40 | 15 | 16.95 | 8.8 | 227518 | 10.8864862 | DE |
156 | -22.9 | -71.7868338558 | 31.9 | 34.4 | 8 | 223322 | 16.85983954 | DE |
260 | 5.25 | 140 | 3.75 | 48.4 | 3.25 | 571905 | 17.99847864 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions